Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2008 2
2012 1
2013 1
2014 2
2015 1
2018 2
2019 1
2020 2
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy.
Zhang Y, Gabere M, Taylor MA, Simoes CC, Dumbauld C, Barro O, Tesfay MZ, Graham AL, Ferdous KU, Savenka AV, Chamcheu JC, Washam CL, Alkam D, Gies A, Byrum SD, Conti M, Post SR, Kelly T, Borad MJ, Cannon MJ, Basnakian A, Nagalo BM. Zhang Y, et al. Among authors: tesfay mz. Front Oncol. 2022 Nov 9;12:1042250. doi: 10.3389/fonc.2022.1042250. eCollection 2022. Front Oncol. 2022. PMID: 36457491 Free PMC article.
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.
Peng KW, Carey T, Lech P, Vandergaast R, Muñoz-Alía MÁ, Packiriswamy N, Gnanadurai C, Krotova K, Tesfay M, Ziegler C, Haselton M, Sevola K, Lathrum C, Reiter S, Narjari R, Balakrishnan B, Suksanpaisan L, Sakuma T, Recker J, Zhang L, Waniger S, Russell L, Petro CD, Kyratsous CA, Baum A, Janecek JL, Lee RM, Ramachandran S, Graham ML, Russell SJ. Peng KW, et al. Among authors: tesfay m. Vaccine. 2022 Apr 1;40(15):2342-2351. doi: 10.1016/j.vaccine.2021.12.063. Epub 2022 Jan 10. Vaccine. 2022. PMID: 35282925 Free PMC article.
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
Suksanpaisan L, Xu R, Tesfay MZ, Bomidi C, Hamm S, Vandergaast R, Jenks N, Steele MB, Ota-Setlik A, Akhtar H, Luckay A, Nowak R, Peng KW, Eldridge JH, Clarke DK, Russell SJ, Diaz RM. Suksanpaisan L, et al. Among authors: tesfay mz. Mol Ther Oncolytics. 2018 Jul 5;10:1-13. doi: 10.1016/j.omto.2018.05.001. eCollection 2018 Sep 28. Mol Ther Oncolytics. 2018. PMID: 29998190 Free PMC article.
Vesiculovirus neutralization by natural IgM and complement.
Tesfay MZ, Ammayappan A, Federspiel MJ, Barber GN, Stojdl D, Peng KW, Russell SJ. Tesfay MZ, et al. J Virol. 2014 Jun;88(11):6148-57. doi: 10.1128/JVI.00074-14. Epub 2014 Mar 19. J Virol. 2014. PMID: 24648451 Free PMC article.
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2.
Vandergaast R, Carey T, Reiter S, Lech P, Gnanadurai C, Tesfay M, Buehler J, Suksanpaisan L, Naik S, Brunton B, Recker J, Haselton M, Ziegler C, Roesler A, Mills JR, Theel E, Weaver SC, Rafael G, Roforth MM, Jerde C, Tran S, Diaz RM, Bexon A, Baum A, Kyratsous CA, Peng KW, Russell SJ. Vandergaast R, et al. Among authors: tesfay m. bioRxiv [Preprint]. 2020 May 27:2020.05.26.117549. doi: 10.1101/2020.05.26.117549. bioRxiv. 2020. PMID: 32577655 Free PMC article. Updated. Preprint.
Adherence to anti-tuberculosis treatment in Tigray, Northern Ethiopia.
Kiros YK, Teklu T, Desalegn F, Tesfay M, Klinkenberg E, Mulugeta A. Kiros YK, et al. Among authors: tesfay m. Public Health Action. 2014 Dec 21;4(Suppl 3):S31-6. doi: 10.5588/pha.14.0054. Public Health Action. 2014. PMID: 26478511 Free PMC article.
17 results